Despite the acceptance of protocols for the prevention of group B streptococcal (GBS) sepsis for the newborn, protocol violations, with subsequent failure to initiate intrapartum antibiotic therapy, occur at many institutions. The causes for GBS prophylaxis protocol violations are not well understood.
Prevention of early onset neonatal group B streptococcal (GBS) sepsis is a major public health concern.
1 Protocols for the prevention of GBS sepsis have been in existence for the past 8 years. [1] [2] [3] Despite the existence of protocols for the prevention of early onset GBS sepsis, protocol violations with subsequent failure to administer appropriate antibiotic therapy are common. 4 -8 There is limited understanding of the factors that lead to failure to appropriately administer intrapartum antibiotic therapy. We report two patients with indicated preterm birth who failed to receive appropriate GBS prophylaxis. Indicated preterm birth may contribute to GBS prophylaxis protocol violations.
Case Number 1
A 23-year-old gravida 1, para 0 with cholestasis and cholelithiasis was admitted at 36 and 4/7 weeks' gestation with worsening symptomatology despite cholestyramine treatment. Amniotic fluid analysis demonstrated lung maturity, and cervical ripening was initiated with intravaginal misoprostil. Oxytocin was administered for augmentation of labor. During labor, the fetal heart rate tracing became nonreassuring with late decelerations. A primary low transverse cesarean section was performed at 1 hour after artificial rupture of the membranes with the delivery of a liveborn male infant weighing 2625 gm with Apgar scores of 6 and 9 at 1 and 5 minutes, respectively. The umbilical artery cord pH was 7.24. At ϳ6 hours after birth, the infant developed respiratory distress and required intubation. Intravenous antibiotics were instituted, and cultures were obtained. The infant rapidly deteriorated and, despite extracorporeal membrane oxygenation, died on day 2 of life from confirmed GBS sepsis. A review of antepartum records revealed a positive GBS culture before admission.
Case Number 2
A 36-year-old gravida 6 para 5 was admitted at 33 and 4/7 weeks' gestation with worsening blood pressure. The patient had known chronic hypertension and was being treated with labetalol 200 mg twice daily. A vaginal culture for GBS was obtained on admission. On hospital day 6, the maternal platelet count had decreased to 97,000 and induction of labor was planned due to suspected superimposed preeclampsia. Cervical ripening and labor ensued after intravaginal misoprostil, and the patient underwent a vaginal delivery of a liveborn male infant weighing 2495 gm with Apgar scores of 8 and 9 at 1 and 5 minutes, respectively. The infant was transferred to the newborn intensive care unit for lethargy and hypotension and was treated for suspected sepsis. The neonate's cultures were negative, and the subsequent neonatal course was unremarkable. Vaginal culture on admission was noted to be positive for GBS.
DISCUSSION
In 1996, The Centers for Disease Control proposed new recommendations for the prevention of early onset GBS sepsis in the newborn. 1 Two management options were suggested as appropriate. The first management scheme proposed routine screening of all women at 35 to 37 weeks' gestation and offering antibiotic treatment at the time of labor for all GBS-positive patients. The second management scheme was the existing American College of Obstetricians and Gynecologists protocol for prevention of GBS sepsis. 2 This protocol is based on offering intrapartum antibiotic prophylaxis to patients who are at increased risk for neonatal GBS sepsis. These risk factors include deliv-
ery before 37 weeks' gestation, prolonged rupture of the membranes for Ͼ18 hours, maternal temperature of Ͼ100.4°F, GBS bacteriuria during pregnancy, or a previously effected child with GBS sepsis. Despite the adoption of protocols for the prevention of early onset GBS sepsis, physician compliance remains a major problem. 4 -7 In a recent review of early onset GBS sepsis, 64% of cases were associated with noncompliance to existing protocols. 7 Gibbs et al. 4 reported on 3721 women screened for GBS at 26 to 28 weeks' gestation. Of 55 infants with preterm birth, there were 8 cases where prophylaxis was omitted, with an 85% compliance rate reported. Lieu et al. 5 reported their experience with the American College of Obstetricians and Gynecologists protocol for GBS sepsis prevention. They assessed adherence to the protocol by chart review and estimated an 81% compliance rate for administering intrapartum antibiotics for preterm deliveries. They report six cases of neonatal GBS infection, of which one was a preterm infant who did not receive antibiotics. They note that "clinical strategies to promote protocol adherence are needed." Cheon-Lee and Amstey 6 assessed compliance to the recommendations of the Centers for Disease Control for GBS prophylaxis at their institution. They report 50 patients with preterm delivery, of which 12 were not treated, giving a compliance rate of 76%. They noted that the greatest area of protocol failure was those patients who did not require antepartum cultures, such as a preterm birth, previously effected child with GBS sepsis, and GBS bacteriuria.
Preterm birth has been characterized as either spontaneous or indicated. 8 Spontaneous preterm birth has been defined as births resulting from preterm labor or preterm premature rupture of membranes. Indicated preterm birth includes maternal or fetal complications of pregnancy in which preterm delivery is recommended for maternal or fetal indications. Indicated preterm delivery is believed to comprise 20% to 30% of cases of preterm delivery. Common complications that may lead to indicated preterm birth include maternal disorders such as hypertension, preeclampsia, liver disease, and diabetes. Fetal complications that may result in indicated preterm birth include intrauterine growth restriction, placental abruption, and oligohydramnios.
Prematurity poses increased risk to the newborn for early onset GBS sepsis. Both the American College of Obstetricians and Gynecologists and Centers for Disease Control protocols recommend the use of intrapartum antibiotics in patients with unknown GBS status who deliver before 37 weeks' gestation, but the emphasis is on spontaneous preterm birth. Although the relationship between GBS infection and spontaneous preterm birth is well recognized by practitioners, it is in this setting of indicated preterm birth that GBS prophylaxis may be overlooked. Protocol violations may result from either failure to obtain a vaginal-rectal culture on admission or failure to institute antibiotics at the time of labor. In our two cases of indicated preterm birth, GBS prophylaxis was not instituted during labor despite recently performed GBS cultures.
We speculate that the attention directed to the medical complications in these cases contributed to the omission of GBS prophylaxis. Strategies to improve GBS prophylaxis compliance at our institution have included the mandatory documentation of GBS carrier status on all patients on our Labor and Delivery board, along with heightened awareness of this potential problem. Practitioners are urged to be aware of the need for GBS prophylaxis in cases of indicated preterm birth.
